Biochemistry, Genetics and Molecular Biology
Protein
100%
Myeloid
93%
Receptor Tyrosine Kinase
86%
Cell Proliferation
50%
Kinase
46%
Eicosanoid Receptor
37%
Gene
35%
Tyrosine
35%
Regulatory Mechanism
32%
Mammalian Target of Rapamycin
32%
Tyrosine Kinase
29%
Isoform
27%
Phosphotransferase
25%
STAT5
21%
SH2 Domain
19%
Survival
19%
Rat
15%
Phosphoinositide 3-Kinase
15%
Germ Cell
12%
Oncogene
12%
Colony Formation
12%
Ubiquitination
12%
Sorafenib
11%
Lipid
10%
Phosphatase
10%
Imatinib
10%
Cell Transformation
9%
Subcellular Localization
9%
Enzyme
9%
Transcription
9%
Germline
8%
Growth Inhibition
8%
Bioinformatics
8%
T Cell Receptor
8%
Apoptosis
8%
Protein Family
8%
FYN
7%
PLK1
7%
Melanosome
7%
Diacylglycerol
7%
Catenin
7%
P53
7%
Colon
7%
Tyrosine Phosphorylation
7%
Receptor Tyrosine Kinase Inhibitors
7%
Fitness
7%
Cyclin-Dependent Kinase
7%
Clonal Evolution
7%
Germline Mutation
7%
Microphthalmia-Associated Transcription Factor
7%
Medicine and Dentistry
Therapeutic Procedure
33%
Patient
28%
Acute Lymphoblastic Leukemia
22%
Adaptor Protein
17%
Cancer Cell
15%
Breast Cancer
15%
Kinase Signaling
15%
Intelligence
12%
Cancer Therapy
12%
Disease
11%
Learning
10%
Phosphatase
10%
Leukemia Cell
9%
Prognosis
9%
Mammalian Target of Rapamycin Inhibitor
9%
Colorectal Cancer
9%
Drug Sensitivity
8%
Melanoma Cell
7%
Medicine
7%
Drug
7%
Tyrosine-Kinase Inhibitor
7%
Nodular Melanoma
7%
FMS-Like Tyrosine Kinase 3
7%
Protein Kinase Syk
7%
Treatment Response
7%
Microphthalmia Associated Transcription Factor
7%
Therapeutics
7%
Health
7%
Antiapoptotic
7%
Ganglioneuroblastoma
7%
Gene Mutation
6%
Pharmacogenomics
6%
Family
6%
Protein
6%
Xenograft
6%
Enzymes
5%
T Cell
5%
Sorafenib
5%
Signal Transduction Pathway
5%
Development
5%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Myeloid Leukemia
58%
Protein Tyrosine Kinase
33%
Malignant Neoplasm
26%
Protein Tyrosine Kinase Inhibitor
15%
Receptor
13%
Melanoma
13%
Leukemia
13%
Binding Site
10%
Pharmacotherapy
10%
Glucocorticoid
9%
Protein Kinase C
9%
Colorectal Cancer
9%
Apoptosis
8%
Tumor Suppressor Protein
8%
Celecoxib
7%
Synergism
7%
Cisplatin
7%
Catenin
7%
Imatinib
7%
Tissue Inhibitor of Metalloproteinase
7%
Phorbol Ester
7%
Metalloproteinase Inhibitor
7%
Rodent
7%
Protein Kinase Fer
7%
Phosphatidylinositol 3 Kinase
7%
Cyclic AMP Dependent Protein Kinase
7%
Chronic Lymphatic Leukemia
7%
Cell Death
7%
Acute Leukemia
7%
Drug Combination
7%
Mastocytosis
6%